Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lasers, Solid-State | 5 | 2024 | 19 | 1.220 |
Why?
|
| Lower Urinary Tract Symptoms | 2 | 2022 | 20 | 1.210 |
Why?
|
| Prostatic Hyperplasia | 4 | 2024 | 35 | 0.720 |
Why?
|
| Kidney Calculi | 5 | 2014 | 34 | 0.650 |
Why?
|
| Prostatic Neoplasms | 2 | 2022 | 493 | 0.610 |
Why?
|
| Prostatectomy | 2 | 2024 | 103 | 0.360 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2008 | 45 | 0.340 |
Why?
|
| Laser Therapy | 1 | 2011 | 40 | 0.330 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2008 | 108 | 0.320 |
Why?
|
| Urolithiasis | 1 | 2009 | 5 | 0.300 |
Why?
|
| Lithotripsy | 3 | 2014 | 11 | 0.290 |
Why?
|
| Cadherins | 1 | 2008 | 90 | 0.280 |
Why?
|
| Urologic Surgical Procedures | 2 | 2020 | 46 | 0.270 |
Why?
|
| Biomarkers, Tumor | 2 | 2008 | 524 | 0.270 |
Why?
|
| Prostate | 3 | 2024 | 122 | 0.240 |
Why?
|
| Preoperative Care | 2 | 2024 | 199 | 0.210 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2024 | 58 | 0.210 |
Why?
|
| Watchful Waiting | 1 | 2022 | 32 | 0.180 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 49 | 0.150 |
Why?
|
| Triage | 1 | 2020 | 135 | 0.140 |
Why?
|
| Male | 9 | 2024 | 31039 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 181 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 801 | 0.140 |
Why?
|
| Humans | 16 | 2024 | 65121 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 205 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 219 | 0.130 |
Why?
|
| Ureteroscopes | 1 | 2015 | 4 | 0.110 |
Why?
|
| Choledocholithiasis | 1 | 2015 | 7 | 0.110 |
Why?
|
| Lithotripsy, Laser | 1 | 2015 | 5 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 675 | 0.110 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2015 | 3 | 0.110 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 49 | 0.110 |
Why?
|
| Ureteral Calculi | 1 | 2014 | 8 | 0.110 |
Why?
|
| Incidental Findings | 1 | 2015 | 51 | 0.110 |
Why?
|
| Laparoscopy | 2 | 2009 | 490 | 0.110 |
Why?
|
| Pancreas | 1 | 2014 | 154 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2014 | 206 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 146 | 0.090 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2012 | 8 | 0.090 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2011 | 2 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2024 | 1322 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2008 | 287 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2008 | 576 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 896 | 0.080 |
Why?
|
| Contrast Media | 1 | 2012 | 432 | 0.070 |
Why?
|
| Tissue Array Analysis | 1 | 2008 | 39 | 0.070 |
Why?
|
| Risk Factors | 3 | 2024 | 5429 | 0.070 |
Why?
|
| Robotics | 1 | 2009 | 86 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 272 | 0.070 |
Why?
|
| Nephrectomy | 1 | 2008 | 92 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2012 | 2061 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 95 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 5609 | 0.060 |
Why?
|
| Prognosis | 2 | 2008 | 1785 | 0.060 |
Why?
|
| Aged | 5 | 2024 | 14955 | 0.060 |
Why?
|
| Transfection | 1 | 2008 | 701 | 0.060 |
Why?
|
| Cell Movement | 1 | 2008 | 480 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2007 | 224 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 324 | 0.060 |
Why?
|
| Adolescent | 3 | 2012 | 6305 | 0.060 |
Why?
|
| Infant | 1 | 2009 | 1693 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1656 | 0.050 |
Why?
|
| Child | 2 | 2012 | 4612 | 0.050 |
Why?
|
| Urinary Tract Infections | 1 | 2024 | 97 | 0.050 |
Why?
|
| Administration, Intravesical | 1 | 2020 | 14 | 0.040 |
Why?
|
| Urologic Diseases | 1 | 2020 | 18 | 0.040 |
Why?
|
| Office Visits | 1 | 2020 | 48 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2020 | 55 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 104 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 18264 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 6862 | 0.030 |
Why?
|
| Electromagnetic Phenomena | 1 | 2014 | 5 | 0.030 |
Why?
|
| Telemedicine | 1 | 2020 | 363 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 94 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2015 | 84 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 372 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 97 | 0.030 |
Why?
|
| Community Health Centers | 1 | 2014 | 98 | 0.030 |
Why?
|
| Swine | 1 | 2014 | 394 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 5785 | 0.020 |
Why?
|
| Young Adult | 2 | 2012 | 4810 | 0.020 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2011 | 7 | 0.020 |
Why?
|
| Demography | 1 | 2011 | 178 | 0.020 |
Why?
|
| Female | 4 | 2015 | 34013 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1219 | 0.020 |
Why?
|
| Adult | 3 | 2012 | 17356 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1559 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2619 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2483 | 0.020 |
Why?
|
| Living Donors | 1 | 2008 | 79 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1141 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2008 | 125 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2008 | 88 | 0.020 |
Why?
|
| Catenins | 1 | 2007 | 14 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2007 | 64 | 0.020 |
Why?
|
| Cystectomy | 1 | 2007 | 35 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 90 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 3307 | 0.020 |
Why?
|
| United States | 1 | 2020 | 8094 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2007 | 610 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 544 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 980 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 21324 | 0.010 |
Why?
|